Discounted Cash Flow Rating
Strong Buy
Return on Equity Rating
Sell
Debt to Equity Rating
Buy
Price to Earnings Rating
Strong Buy
Analyst Rating
Buy
Simple Moving Average
Neutral
Exponential Moving Average
Neutral
Relative Strength Index
Buy
Standard Deviation
Strong Sell
Williams %R
Strong Buy
Average Directional Index
Sell
Insider Trading
Strong Buy
Wall Street Data Solutions Rating
Buy
A
Cumberland Pharmaceuticals Inc (CPIX)
Pharmaceutical Preparations
https://www.cumberlandpharma.com
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, RediTrex, Sancuso, Vaprisol and Vibativ.
2525 WEST END AVENUE, SUITE 950
NASHVILLE,, TN
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
08/11/2009
Market Cap
19,451,790
Shares Outstanding
14,910,000
Weighted SO
14,904,786
Total Employees
N/A
Upcoming Earnings
N/A
Beta
0.2300
Last Div
0.0000
Range
1.38-2.36
Chg
-0.0100
Avg Vol
6641
Mkt Cap
19451790
Exch
NASDAQ
Country
US
Phone
615 255 0068
DCF Diff
-8.5609
DCF
10.5059
Div Yield
0.0000
P/S
0.5148
EV Multiple
-12.7707
P/FV
0.7394
Div Yield %
0.0000
P/E
-1.8784
PEG
-0.4731
Payout
0.0000
Current Ratio
1.4373
Quick Ratio
1.2635
Cash Ratio
0.7003
DSO
112.2443
DIO
155.9759
Op Cycle
268.2203
DPO
453.4819
CCC
-185.2616
Gross Margin
0.7336
Op Margin
-0.1930
Pretax Margin
-0.2730
Net Margin
-0.2745
Eff Tax Rate
-0.0053
ROA
-0.1321
ROE
-0.3474
ROCE
-0.1357
NI/EBT
1.0055
EBT/EBIT
1.4144
EBIT/Rev
-0.1930
Debt Ratio
0.2097
D/E
0.6250
LT Debt/Cap
0.3792
Total Debt/Cap
0.3846
Int Coverage
-25.9490
CF/Debt
-0.0435
Equity Multi
2.9800
Rec Turnover
3.2518
Pay Turnover
0.8049
Inv Turnover
2.3401
FA Turnover
5.6372
Asset Turnover
0.4812
OCF/Share
-0.0507
FCF/Share
-0.0710
Cash/Share
1.2280
OCF/Sales
-0.0189
FCF/OCF
1.4007
CF Coverage
-0.0435
ST Coverage
-1.8994
CapEx Coverage
-2.4954
Div&CapEx Cov
-2.4954
P/BV
0.7394
P/B
0.7394
P/S
0.5148
P/E
-1.8784
P/FCF
-19.4049
P/OCF
-27.2246
P/CF
-27.2246
PEG
-0.4731
P/S
0.5148
EV Multiple
-12.7707
P/FV
0.7394
DPS
0.0000
Latest Headlines (EST)
No Headlines Found
Revenue Product Segmentation
Year | Purchases | Sales | Total Bought | Total Sold |
---|
Transaction Date | Name | Type Of Owner | Price | Securities Owned | Securities Transacted | Security Name | Transaction Type |
---|
Less Than 3 Months
124.25K Shares Bought (100.00 %)
0.00 Shares Sold (0.00%)
3 - 6 Months
0.00 Shares Bought (0.00 %)
28.75K Shares Sold (100.00%)
6 - 9 Months
11.07K Shares Bought (96.92 %)
352.00 Shares Sold (3.08%)
9 - 12 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0 %)
Investor Name | Investment Discretion | Type of Security | Shares Owned | Avg Price Paid | Market Value | Change In Market Value | Change In Market Value (%) | Ownership | Weight |
---|
Date | Investors Holding | Closed Positions | Increased Positions | Reduced Positions | New Positions | Total Invested | Put/Call Ratio | Total Calls | Total Puts |
---|
Owner | Shares Owned |
---|
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Revenue | 13.50M | ▲ 13.68M | ▼ 10.26M | ▼ 8.32M | ▲ 9.12M | ▲ 9.35M | ▼ 8.50M |
Cost Of Revenue | 2.87M | ▼ 2.82M | ▼ 2.27M | ▲ 3.33M | ▼ 2.65M | ▲ 2.73M | ▲ 2.73M |
Gross Profit | 10.63M | ▲ 10.86M | ▼ 8.00M | ▼ 4.99M | ▲ 6.47M | ▲ 6.63M | ▼ 5.77M |
Gross Profit Ratio | 0.79 | ▲ 0.79 | ▼ 0.78 | ▼ 0.60 | ▲ 0.71 | ▼ 0.71 | ▼ 0.68 |
Research And Development Expenses | 2.69M | ▼ 2.08M | ▼ 1.40M | ▲ 1.61M | ▼ 1.41M | ▼ 1.26M | ▼ 1.16M |
General And Administrative Expenses | 3.67M | ▼ 3.14M | ▲ 3.59M | ▼ 3.41M | ▲ 3.51M | ▼ 3.44M | ▼ 2.37M |
Selling And Marketing Expenses | 5.71M | ▼ 5.59M | ▼ 3.60M | ▼ 3.31M | ▲ 3.38M | ▲ 4.76M | ▼ 4.15M |
Selling General And Administrative Expenses | 9.38M | ▼ 8.73M | ▼ 7.19M | ▼ 6.72M | ▲ 6.89M | ▲ 7.45M | ▼ 6.71M |
Other Expenses | 823.01K | ▲ 1.05M | ▲ 1.15M | ▼ 1.02M | ▼ 458.22K | ▲ 4.54M | ▼ 1.11M |
Operating Expenses | 12.89M | ▼ 11.86M | ▼ 9.74M | ▼ 9.35M | ▼ 8.75M | ▼ 8.72M | ▼ 7.87M |
Cost And Expenses | 15.76M | ▼ 14.68M | ▼ 12.01M | ▲ 12.67M | ▼ 11.40M | ▲ 11.44M | ▼ 10.60M |
Interest Income | 166.06K | ▼ 47.45K | ▼ 4.79K | ▲ 6.67K | ▲ 45.70K | ▲ 81.00K | ▲ 96.75K |
Interest Expense | 136.33K | ▼ 29.20K | ▲ 35.90K | ▼ 27.73K | ▲ 179.46K | ▼ 178.79K | ▼ 118.53K |
Depreciation And Amortization | 823.01K | ▲ 1.13M | ▲ 1.22M | ▼ 1.08M | ▼ 557.18K | ▲ 1.23M | ▲ 1.44M |
Ebitda | -1.27M | ▲ 175.26K | ▼ -517.27K | ▼ -3.27M | ▲ -1.72M | ▲ -854.90K | ▲ -663.81K |
Ebitda Ratio | -0.09 | ▲ 0.01 | ▼ -0.05 | ▼ -0.39 | ▲ -0.19 | ▲ -0.09 | ▲ -0.08 |
Operating Income | -2.26M | ▲ -997.41K | ▼ -1.75M | ▼ -4.35M | ▲ -2.28M | ▲ -2.09M | ▼ -2.10M |
Operating Income Ratio | -0.17 | ▲ -0.07 | ▼ -0.17 | ▼ -0.52 | ▲ -0.25 | ▲ -0.22 | ▼ -0.25 |
Total Other Income Expenses Net | 29.74K | ▼ 18.25K | ▼ -31.11K | ▼ -567.61K | ▲ -133.76K | ▼ -4.19M | ▲ 208.65K |
Income Before Tax | -2.23M | ▲ -979.16K | ▼ -1.78M | ▼ -4.38M | ▲ -2.41M | ▼ -6.28M | ▲ -1.89M |
Income Before Tax Ratio | -0.17 | ▲ -0.07 | ▼ -0.17 | ▼ -0.53 | ▲ -0.26 | ▼ -0.67 | ▲ -0.22 |
Income Tax Expense | 4.16K | ▼ -6.81K | ▲ 10.48K | ▲ 12.52K | ▲ 48.15K | ▼ 24.96K | ▼ 11.44K |
Net Income | -2.22M | ▲ -960.71K | ▲ -883.78K | ▼ -3.85M | ▲ -2.46M | ▼ -6.29M | ▲ -1.95M |
Net Income Ratio | -0.16 | ▲ -0.07 | ▼ -0.09 | ▼ -0.46 | ▲ -0.27 | ▼ -0.67 | ▲ -0.23 |
Eps | -0.14 | ▲ -0.06 | -0.06 | ▼ -0.26 | ▲ -0.17 | ▼ -0.44 | ▲ -0.14 |
Eps Diluted | -0.14 | ▲ -0.06 | -0.06 | ▼ -0.26 | ▲ -0.17 | ▼ -0.44 | ▲ -0.14 |
Weighted Average Shs Out | 15.52M | ▼ 15.22M | ▼ 15.03M | ▼ 14.80M | ▼ 14.40M | ▼ 14.16M | ▼ 14.10M |
Weighted Average Shs Out Dil | 15.52M | ▼ 15.23M | ▼ 15.03M | ▼ 14.80M | ▼ 14.40M | ▼ 14.16M | ▼ 14.10M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Cash And Cash Equivalents | 27.94M | ▲ 28.21M | ▼ 24.75M | ▲ 27.04M | ▼ 19.76M | ▼ 18.32M | ▲ 18.55M |
Short Term Investments | 8.29M | ▼ 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cash And Short Term Investments | 36.23M | ▼ 28.21M | ▼ 24.75M | ▲ 27.04M | ▼ 19.76M | ▼ 18.32M | ▲ 18.55M |
Net Receivables | 7.84M | ▲ 7.86M | ▲ 12.38M | ▼ 6.88M | ▲ 13.16M | ▼ 9.76M | ▲ 10.65M |
Inventory | 27.83M | ▼ 8.87M | ▲ 10.64M | ▼ 8.43M | ▲ 9.40M | ▼ 4.61M | ▼ 4.33M |
Other Current Assets | 2.96M | ▼ 2.76M | ▼ 2.20M | ▲ 3.34M | ▲ 3.55M | ▼ 3.03M | ▼ 2.68M |
Total Current Assets | 74.87M | ▼ 50.16M | ▼ 49.97M | ▼ 45.69M | ▲ 45.87M | ▼ 35.71M | ▲ 36.21M |
Property Plant Equipment Net | 771.21K | ▲ 3.71M | ▼ 2.60M | ▼ 1.47M | ▲ 5.50M | ▲ 7.04M | ▼ 6.89M |
Goodwill | 784.00K | ▲ 882.00K | 882.00K | 882.00K | ▲ 914.00K | 914.00K | 914.00K |
Intangible Assets | 33.66M | ▼ 30.92M | ▼ 28.12M | ▼ 23.95M | ▲ 30.59M | ▼ 22.61M | ▼ 21.52M |
Goodwill And Intangible Assets | 34.44M | ▼ 31.80M | ▼ 29.00M | ▼ 24.84M | ▲ 31.50M | ▼ 23.52M | ▼ 22.44M |
Long Term Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Tax Assets | 87.21K | ▼ 21.80K | ▼ 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Non Current Assets | 2.53M | ▲ 18.85M | ▼ 14.89M | ▼ 12.47M | ▼ 10.05M | ▲ 15.50M | ▲ 15.98M |
Total Non Current Assets | 37.83M | ▲ 54.39M | ▼ 46.49M | ▼ 38.77M | ▲ 47.05M | ▼ 46.06M | ▼ 45.30M |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Assets | 112.69M | ▼ 104.55M | ▼ 96.46M | ▼ 84.46M | ▲ 92.93M | ▼ 81.78M | ▼ 81.51M |
Account Payables | 11.09M | ▼ 9.99M | ▲ 13.40M | ▼ 9.64M | ▲ 10.82M | ▲ 14.04M | ▼ 13.08M |
Short Term Debt | 0.00 | ▲ 920.43K | ▲ 1.02M | ▼ 969.68K | ▼ 172.91K | ▲ 348.09K | ▲ 362.24K |
Tax Payables | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 45.77K | ▼ 0.00 |
Deferred Revenue | 0.00 | ▲ 5.50M | ▼ 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Current Liabilities | 16.71M | ▼ 7.74M | ▲ 11.25M | ▼ 8.67M | ▲ 17.59M | ▼ 13.60M | ▼ 12.99M |
Total Current Liabilities | 27.80M | ▼ 24.15M | ▲ 25.67M | ▼ 19.28M | ▲ 28.58M | ▼ 27.98M | ▼ 26.43M |
Long Term Debt | 20.00M | ▲ 20.58M | ▼ 16.06M | ▼ 15.09M | ▲ 20.79M | ▼ 12.78M | ▲ 16.08M |
Deferred Revenue Non Current | 0.00 | 0.00 | 0.00 | ▲ 3.43M | ▼ 2.52M | ▲ 2.89M | ▼ 0.00 |
Deferred Tax Liabilities Non Current | 0.00 | 0.00 | 0.00 | ▼ -3.43M | ▲ -2.52M | ▲ 5.30M | ▼ 0.00 |
Other Non Current Liabilities | 9.32M | ▼ 8.74M | ▼ 7.86M | ▼ 4.05M | ▲ 7.59M | ▼ 3.56M | ▲ 11.81M |
Total Non Current Liabilities | 29.32M | ▼ 29.31M | ▼ 23.92M | ▼ 22.58M | ▲ 28.37M | ▼ 24.53M | ▲ 27.89M |
Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 1.00 | ▼ 0.00 |
Capital Lease Obligations | 0.00 | ▲ 3.00M | ▼ 2.08M | ▼ 1.06M | ▲ 4.76M | ▲ 5.30M | ▼ 5.20M |
Total Liabilities | 57.12M | ▼ 53.46M | ▼ 49.59M | ▼ 41.86M | ▲ 56.95M | ▼ 52.52M | ▲ 54.32M |
Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Common Stock | 51.10M | ▼ 49.91M | ▼ 49.12M | ▼ 48.45M | ▼ 47.47M | ▼ 47.09M | ▼ 46.92M |
Retained Earnings | 4.75M | ▼ 1.21M | ▼ -2.13M | ▼ -5.64M | ▼ -11.21M | ▼ -17.49M | ▼ -19.43M |
Accumulated Other Comprehensive Income Loss | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Total Stockholders Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Stockholders Equity | 55.84M | ▼ 51.12M | ▼ 46.99M | ▼ 42.81M | ▼ 36.27M | ▼ 29.60M | ▼ 27.49M |
Total Equity | 55.57M | ▼ 51.09M | ▼ 46.87M | ▼ 42.60M | ▼ 35.97M | ▼ 29.26M | ▼ 27.19M |
Total Liabilities And Stockholders Equity | 112.69M | ▼ 104.55M | ▼ 96.46M | ▼ 84.46M | ▲ 92.93M | ▼ 81.78M | ▼ 81.51M |
Minority Interest | -274.27K | ▲ -37.62K | ▼ -117.12K | ▼ -212.33K | ▼ -292.13K | ▼ -343.57K | ▲ -299.78K |
Total Liabilities And Total Equity | 112.69M | ▼ 104.55M | ▼ 96.46M | ▼ 84.46M | ▲ 92.93M | ▼ 81.78M | ▼ 81.51M |
Total Investments | 8.29M | ▼ 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Debt | 20.00M | ▲ 21.50M | ▼ 17.08M | ▼ 16.06M | ▲ 20.96M | ▼ 18.43M | ▲ 21.65M |
Net Debt | -7.94M | ▲ -6.72M | ▼ -7.68M | ▼ -10.98M | ▲ 1.20M | ▼ 106.86K | ▲ 3.10M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Net Income | -2.24M | ▲ -972.35K | ▲ -915.47K | ▼ -2.39M | ▼ -2.46M | ▼ -6.29M | ▲ -1.95M |
Depreciation And Amortization | 874.65K | ▲ 1.13M | ▲ 1.22M | ▼ 1.08M | ▼ 511.48K | ▲ 1.23M | ▲ 1.44M |
Deferred Income Tax | 81.89K | ▼ 21.80K | ▼ 21.80K | ▲ 503.32K | ▼ 48.15K | ▼ -5.27M | ▲ 0.00 |
Stock Based Compensation | 359.46K | ▲ 378.08K | ▼ 241.18K | ▼ 224.79K | ▼ 126.91K | ▼ 93.89K | ▼ 78.75K |
Change In Working Capital | 4.71M | ▼ 561.20K | ▼ -140.67K | ▲ 5.29M | ▲ 8.47M | ▼ 2.19M | ▼ -1.39M |
Accounts Receivables | -789.11K | ▼ -1.95M | ▼ -2.70M | ▲ 2.97M | ▼ 1.92M | ▲ 2.51M | ▼ -1.07M |
Inventory | 149.09K | ▼ -1.11M | ▲ 434.68K | ▲ 2.26M | ▼ 36.20K | ▼ -441.50K | ▲ 170.47K |
Accounts Payables | 5.90M | ▼ 4.95M | ▼ 3.15M | ▼ 2.34M | ▲ 7.74M | ▼ 1.82M | ▼ -645.54K |
Other Working Capital | -556.71K | ▼ -1.33M | ▲ -1.03M | ▼ -2.28M | ▲ -1.24M | ▼ -1.70M | ▲ 148.52K |
Other Non Cash Items | -62.91K | ▼ -256.95K | ▲ 423.20K | ▼ -2.74M | ▼ -3.85M | ▲ 9.08M | ▼ 4.18M |
Net Cash Provided By Operating Activities | 3.72M | ▼ 857.00K | ▼ 853.92K | ▲ 1.96M | ▲ 2.84M | ▼ 1.04M | ▼ -2.14M |
Investments In Property Plant And Equipment | -2.69M | ▲ -354.74K | ▲ -211.27K | ▲ -79.36K | ▼ -846.72K | ▲ -86.72K | ▲ -58.19K |
Acquisitions Net | 2.41M | ▼ 274.94K | ▼ 0.00 | 0.00 | ▲ 13.50M | ▼ 0.00 | 0.00 |
Purchases Of Investments | 738.96K | ▼ -2.12M | ▲ 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Sales Maturities Of Investments | 540.86K | ▲ 4.38M | ▼ 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | -22.41M | ▲ -274.94K | ▲ -104.75K | ▲ 52.57K | ▼ -12.50M | ▲ 347.36K | ▼ -16.57K |
Net Cash Used For Investing Activities | -21.41M | ▲ 1.90M | ▼ -316.02K | ▲ -26.80K | ▲ 153.28K | ▲ 260.64K | ▼ -58.19K |
Debt Repayment | -12.00M | ▼ -21.50M | ▲ -17.00M | ▲ -14.00M | ▲ -7.70M | ▲ -138.98K | ▼ -3.30M |
Common Stock Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Common Stock Repurchased | -496.46K | ▼ -901.14K | ▲ -300.06K | ▼ -361.19K | ▲ -189.66K | ▲ -188.97K | ▼ -247.61K |
Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 19.86M | ▲ 20.88M | ▼ 14.87M | ▼ 13.63M | ▼ 5.11M | ▼ -1.16M | ▲ -630.70K |
Net Cash Used Provided By Financing Activities | 7.37M | ▼ -1.53M | ▼ -2.43M | ▲ -735.30K | ▼ -2.78M | ▲ -1.49M | ▲ 2.42M |
Effect Of Forex Changes On Cash | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 186.34K | ▼ 0.00 |
Net Change In Cash | -10.32M | ▲ 1.23M | ▼ -1.89M | ▲ 1.20M | ▼ 216.43K | ▼ -186.34K | ▲ 226.86K |
Cash At End Of Period | 27.94M | ▲ 28.21M | ▼ 24.75M | ▲ 27.04M | ▼ 19.76M | ▼ 18.32M | ▲ 18.55M |
Cash At Beginning Of Period | 38.26M | ▼ 26.98M | ▼ 26.65M | ▼ 25.84M | ▼ 19.54M | ▼ 18.51M | ▼ 18.32M |
Operating Cash Flow | 3.72M | ▼ 857.00K | ▼ 853.92K | ▲ 1.96M | ▲ 2.84M | ▼ 1.04M | ▼ -2.14M |
Capital Expenditure | -2.69M | ▲ -354.74K | ▲ -211.27K | ▲ -79.36K | ▼ -846.72K | ▲ -86.72K | ▲ -58.19K |
Free Cash Flow | 1.03M | ▼ 502.26K | ▲ 642.65K | ▲ 1.88M | ▲ 2.00M | ▼ 953.40K | ▼ -2.19M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
Generating AI Summary...
(This could take up to 5 minutes)